These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29490904)

  • 1. Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.
    Doi T; Moriya T; Fujita Y; Minagawa N; Usami M; Sasaki T; Abe H; Kishi S; Murakami T; Ouchi M; Ichien G; Yamamoto K; Ikeda H; Koezuka Y; Takamatsu N; Shima K; Mauer M; Nagai K; Tominaga T
    Diabetes; 2018 May; 67(5):986-993. PubMed ID: 29490904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
    Li Q; Feng L; Li J; Chen Q
    Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion.
    Moriya T; Yamagishi T; Matsubara M; Ouchi M
    J Diabetes Complications; 2019 May; 33(5):368-373. PubMed ID: 30846231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study.
    Najafian B; Masood A; Malloy PC; Campos A; Hansen BC; Mauer M; Caramori ML
    Diabetes Metab Res Rev; 2011 May; 27(4):341-7. PubMed ID: 21370383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
    Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
    Abe H
    Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
    Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
    Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy.
    Bakoush O; Tencer J; Tapia J; Rippe B; Torffvit O
    Kidney Int; 2002 Jan; 61(1):203-8. PubMed ID: 11786102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
    Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
    Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.
    Fu WJ; Fang YG; Deng RT; Wen S; Chen ML; Huang ZH; Tang HH; Xiong SL; Huang XZ; Wang Q
    Endocrine; 2013 Apr; 43(2):346-50. PubMed ID: 22798249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.